Novel anti-AD dimeric leads:from relieving symptoms to modifying diseases via multi-targets

来源 :2019全国老年痴呆与认知障碍相关疾病学术大会 | 被引量 : 0次 | 上传用户:wkxhm123
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Alzheimer disease(AD)has now become the most common brain disorder among the older population.In addition,the currently existing therapeutics only offer temporary symptomatic relieves.
其他文献
Tumor drug resistance is the main reason for the failure of tumor chemotherapy,but the underlying mechanisms are various,which is a big problem in the clinical treatment.A large number of studies have
会议
Chronic myeloid leukemia(CML)is a clonal malignant disorder of pluripotent hematopoietic stem cells(HSCs)characterized by the formation of the novel breakpoint cluster region-Abelson tyrosine kinase(B
会议
Triple-negative breast cancer(TNBC)are characterized by high vascularity and frequent metastasis.Here,we found that activation of G protein-coupled estrogen receptor(GPER)by its specific agonist G-1 c
会议
会议
会议
Background: Bisphenol A(BPA)is a chemical with widespread human exposure suspected of causing low-dose effects.Bisphenol-S(BPS)which structurally similar to BPA is intended to replace BPA in plastic.
会议
会议
Cisplatin is currently one of the most effective chemotherapeutic drugs for the treatment of ovarian and lung cancer.Whereas,resistance to cisplatin is common and it often leads to local and distant f
会议
会议